CB
EDSA icon

Chemical Bank’s Edesa Biotech EDSA Stock Holding History

Chemical Bank’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-51
Closed -$24K – 380
2017
Q1 		$24K Buy
+51
New +$27.1K ﹤0.01% 369

Other funds holding EDSA

AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Chemical Bank's EDSA Position: Q2 2017 in Review

Chemical Bank sold out of Edesa Biotech (EDSA) in Q2 2017, closing a stake of 51 shares — an estimated $24K sold.

Chemical Bank first reported a position in EDSA in Q1 2017 and held it in 1 quarter. The position peaked at $24K in Q1 2017. 9 funds tracked by Wall St. Rank hold EDSA as of Q2 2017.

  • Chemical Bank reported no remaining Edesa Biotech position as of Q2 2017 after selling out during the quarter.
  • Chemical Bank sold 51 Edesa Biotech shares in Q2 2017, an estimated $24K.
  • Chemical Bank first reported a position in Edesa Biotech in Q1 2017 and held it in 1 quarter.
  • Chemical Bank's Edesa Biotech position peaked at $24K in Q1 2017.
  • 9 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2017.

Based on Chemical Bank's 13F filing for Q2 2017, filed 10 Aug 2017.